Skip to the page

Data / Drug companies / Venlafaxine

Venlafaxine: 33 companies and 116 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Venlafaxine is listed in the FDA National Drug Code Directory by 33 companies, with 116 products in commercial distribution. 115 of the products (99.1%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; tablet, extended release; tablet, coated, and the newest product started marketing on October 19, 2026.

The request: Get every company that lists venlafaxine in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
33
Products
116
Generic (ANDA) products
115 (99.1%)
Application numbers
13
Routes
Oral
openFDA record search
api.fda.gov

Companies that list venlafaxine

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
BluePoint Laboratories9tablet; tablet, extended releaseGeneric drugs (ANDA)April 30, 2021
Cadila Pharmaceuticals Limited8tablet; tablet, coatedGeneric drugs (ANDA)December 3, 2018
Remedyrepack Inc.6tablet, extended release; tabletGeneric drugs (ANDA)October 19, 2026
Alembic Pharmaceuticals Inc.5tabletGeneric drugs (ANDA)October 1, 2015
Alembic Pharmaceuticals Limited5tabletGeneric drugs (ANDA)October 1, 2015
Golden State Medical Supply, Inc.5tabletGeneric drugs (ANDA)June 13, 2008
Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.5tabletGeneric drugs (ANDA)July 19, 2021
NuCare Pharmaceuticals,Inc.5tabletGeneric drugs (ANDA)October 1, 2015
Sun Pharmaceutical Industries, Inc.5tabletGeneric drugs (ANDA)June 13, 2008
Zydus Pharmaceuticals USA Inc.5tabletGeneric drugs (ANDA)June 13, 2008
Ajanta Pharma USA Inc.4tablet, extended releaseGeneric drugs (ANDA)April 12, 2023
Ascend Laboratories, LLC4tablet, extended releaseGeneric drugs (ANDA)June 11, 2021
Camber Pharmaceuticals, Inc.4tablet, extended releaseGeneric drugs (ANDA)October 23, 2020
Rising Pharma Holdings, Inc.4tablet, extended releaseGeneric drugs (ANDA)November 28, 2022
XLCare Pharmaceuticals, Inc.4tablet, extended releaseGeneric drugs (ANDA)February 26, 2021
Zydus Lifesciences Limited4tablet, extended releaseGeneric drugs (ANDA)September 1, 2022
Zydus Pharmaceuticals USA Inc.4tablet, extended releaseGeneric drugs (ANDA)September 1, 2022
A-S Medication Solutions3tabletGeneric drugs (ANDA)October 1, 2015
American Health Packaging3tabletGeneric drugs (ANDA)September 29, 2015
Bryant Ranch Prepack3tabletGeneric drugs (ANDA)October 1, 2015
Modavar Pharmaceuticals LLC3tablet, coatedGeneric drugs (ANDA)January 5, 2018
Proficient Rx LP3tabletGeneric drugs (ANDA)October 1, 2015
Coupler LLC2tabletGeneric drugs (ANDA)June 8, 2026
Dr. Reddy's Laboratories Inc.2tablet, extended releaseGeneric drugs (ANDA)September 20, 2021
Northwind Health Company, LLC2tabletGeneric drugs (ANDA)June 10, 2021
St. Mary's Medical Park Pharmacy2tabletGeneric drugs (ANDA)April 21, 2023
Almatica Pharma LLC1tablet, extended releaseNew drug applications (NDA)June 30, 2022
Aphena Pharma Solutions - Tennessee, LLC1tabletGeneric drugs (ANDA)June 13, 2008
Bryant Ranch Prepack1tabletGeneric drugs (ANDA)June 13, 2008
NCS HealthCare of Ky, LLC DBA Vangard Labs1tabletGeneric drugs (ANDA)June 13, 2008
PD-Rx Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)June 13, 2008
Preferred Pharmaceuticals Inc.1tablet, extended releaseGeneric drugs (ANDA)February 10, 2025
Proficient Rx LP1tabletGeneric drugs (ANDA)October 1, 2015

Dosage forms

Dosage formProductsShare
Tablet7060.3%
Tablet, extended release4034.5%
Tablet, coated65.2%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)11599.1%
New drug applications (NDA)10.9%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.